盘山算命准的师傅(六合哪里有算卦准的) (今日更新中)

A Wilson County, Tennessee, woman is facing a lawsuit after she posted a negative review on Yelp about a middle Tennessee doctor in November. Kelly Beavers is accused of defamation and libel, and false light for a post she made about Dr. Kaveer Nandigam of Nandigam Neurology in Murfreesboro. Her Yelp review, which remained on the website three weeks after she originally posted it, said, "This "Dr's" behavior today was totally unprofessional and unethical to put it mildly. I will be reporting him to the State of TN Medical Review Board and be filing a formal complaint. How this guy is in business is beyond me. Since when did they start allowing Doctors, to throw a complete temper tantrum in front of Patients and slam things when they get upset? He does not belong in the medical field at all." On November 27, the attorney for Nandigam Neurology filed a ,000 lawsuit against Beavers and her friend's son who posted a negative review on Google as well and has since been accused of conspiracy. Beavers said he wrote the review after he overheard her conversation. The lawsuit said the review "contained false, disparaging, and misleading statements." The lawsuit also suggested that the second defendant "was specifically recruited" by Beavers to post false and misleading statements. The plaintiff is also demanding Beavers to remove the post and for the court to issue an injunction to prohibit any further statements against Nandigam Neurology. As of this week, Nandigram Neurology only has Beavers' review and another post that gave the business five stars. Meanwhile, the company has 4.3 out 5 stars from the 21 reviews on Google. "Just in shock, I can't believe it," Beavers said. "They just don't want any negative reviews and they don't want people to talk about or give a bad review." Beavers said she has no regrets leaving the review on Yelp despite the legal action against her. She claimed she posted the review after what she called a disrespectful and shocking experience. After being referred to Nandigam Neurology, Beavers brought her 67-year-old father for dizziness and memory loss, which may have been early signs of dementia. There have been prior interactions with the staff but never with the doctor until the last visit. Beavers says the interaction seemed fine at first, but that said the doctor then threw a temper tantrum and slammed his clipboard when he realized she was recording the appointment on her cell phone, which is something she has done with other doctor visits. "Sometimes we all have things we forget, so that's why I record every doctor's visit. I want to make sure that I'm doing everything right," she explained. "He literally snapped and demanded my phone." Since Tennessee is a one-party consent state, she could record on her phone without the need for permission. Nevertheless, she claims she deleted the recording after he demanded her to. Later that day, an office employee called her to get her version of the story and deemed it was likely a miscommunication. The employee said phones were not allowed in the office, and the situation could have been mitigated if there was a prior notice to record. Beavers believed she should have been taken aside to address any concerns. Ken Paulson of the Free Speech Center, a nonpartisan educational institution that teaches how the First Amendment works in society, said there always needs to be a conscious effort to differentiate between stating an opinion or fact on platforms like Yelp. Words like unethical, dishonest or lying have the potential to damage a reputation or business if believed widely. "Don't state things you cannot back up. It's okay to say you didn't like this pizza or the anchovies were terrible because that's opinion, but you can't say they can't make this pizza without washing their hands. It's a difference in expressing an opinion and damaging a business or person," Paulson said. In reality, lawsuits like what Beavers is facing could be disputed in court and avoid the judicial process under the newly enacted Tennessee Public Participation Act otherwise known as an Anti-SLAPP (Strategic Lawsuit Against Public Participation) legislation. The act hopes to prevent filing lawsuits as a form of intimidation and protect First Amendment rights, and has slowed down what was a common type of lawsuit in the past. "It allows you when you're sued to go to a judge and say, 'This is nonsense, they're just angry, I didn't cause any damage, will you dismiss this?'" Paulson explained. "They have to prove in the long run that you damaged them and spoke untruths." A judge is there to weed out cases that have no merit but if it is not dismissed, will still have to go through the judicial process. Speech Defense and Anti-SLAPP Lawyer Daniel Horwitz expressed his approval for the legislation when it was passed. He said an overwhelming majority of defamation and other speech-based lawsuits are not filed because a person has suffered an actual legal injury. Horwitz claims the purpose is to punish people for lawfully exercising their right to speak freely about a topic that the suing plaintiff wants to censor. “Tennessee’s new anti-SLAPP statute was specifically designed to punish abusive litigants who file baseless claims against people for exercising their First Amendment rights. The Yelp review is not even conceivably tortious, and the defendants should not give in to a bogus lawsuit like this one. Instead, they should fight back, get the plaintiff sanctioned, and make the plaintiff pay their attorney’s fees under the newly enacted Tennessee Public Participation Act," Horwitz said in a statement to NewsChannel 5.Beavers said she plans to a hire a lawyer and fight the lawsuit. Meanwhile, a request for comment for Nandigam Neurology has been left. 5817

Doctors are seeing more children with an illness that can look a lot like the flu or cold. It's known as RSV. It stands for respiratory syncytial virus. It comes with the typical runny nose, cough and congestion we see in the wintertime. Adults can usually get over RSV without a problem. But it can be a lot more severe for young children.“From a newborn to a 3- or 4-year-aged child, and they go to a daycare or they're exposed to other kids who have a runny nose, cough or congestion. These kids can fall sicker much more, and will have more respiratory distress and dehydration than kids who are older,” says Dr. Purva Grover with Cleveland Clinic. Respiratory distress and dehydration are what makes RSV different from the typical cold. Doctors say some of the signs include shortness of breath and difficulty breathing. Parents may be able to tell this is happening in a child if they're heavily breathing from both their nose and chest, as well as grunting noises. It's important that families see a doctor before this becomes respiratory failure. There isn't a vaccine specifically for RSV. But some doctors say they've been able to treat it with other vaccines. “There is a vaccine which is actually an antibody treatment that we give to the most vulnerable premature infants, those that are in their first year of life and were born very prematurely,” says Dr. James Gaensbauer, a pediatrics and infectious disease specialist at Denver Health. “But it's not an ideal thing, you have to give a shot every month for every five months that is typically the season.” Doctors can also do other things to treat the symptoms, like giving kids extra oxygen.RSV usually lasts about two weeks. 1707

BALTIMORE, Md. – For 95-year-old Betty Cooke, her lifelong passion of turning metal into wearable works of art began in the 1940s. “I was always interested in making things, whether it's metal clay or whatever,” she said. “And I kind of took to this and I had a good feel for the simplicity of it.” It’s a simplicity celebrated not just at her Baltimore store, but also at the Baltimore Museum of Art. “They really stand out, they're really sculptural, they're really dimensional – they move on the body,” said Virginia Anderson, Baltimore Museum of Art Curator of American Art. Betty’s works are just one part of “2020 Vision,” a pledge by the museum in 2020 to only purchase art by female artists. “Of course, it was duly noted that this is this centennial of white women receiving the votes in the United States,” said Christopher Bedford, Director of the Baltimore Museum of Art. “So, we thought ‘well, this would be a great moment to analyze our collection, begin to understand some of our historical deficits.” How big are those gender deficits? A study last year published in the Public Library of Science looked at 18 major museums in the U.S. and found that 85 percent of the artists in their collections were white and 87 percent were men. This, despite the fact that half of the professional artists in the U.S. are women. At the Baltimore Museum of Art, the disparity is even more lopsided. “We have roughly four percent,” Bedford said. “Four percent of our collection is works by women.” Now, though, with 21 of their 23 curators being women, the Baltimore Museum of Art plans to spend at least .5 million this year, acquiring pieces by female artists – like those created by Betty Cooke. “This is a big moment for the women,” Cooke said. “I hope and I expect it to continue and I think it's pretty great.”Another recent study found that smaller museums seem to be doing better than larger ones, when it comes to buying works by female artists. Larger museums, though, point out that they often face not just financial constraints, but also by what art wealthy donors choose to offer the museums. 2126

INDIANAPOLIS — A new drug from Eli Lilly and Company to help hospitalized COVID-19 patients requiring oxygen has received emergency use authorization from the U.S. Food and Drug Administration.Barivitinib, which is used in combination with remdesivir, can be given to both adult and pediatric patients two years old and older who are suspected to have or have a confirmed case of COVID-19 and need supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation. "Since the start of the COVID-19 pandemic, Lilly has been committed to finding potential treatments to help people around the world who've been impacted by this virus," David A. Ricks, Lilly chairman and CEO, said in a press release. "Today's FDA action for baricitinib marks the second Lilly therapy to be granted an EUA, in addition to the recent neutralizing antibody EUA for high-risk non-hospitalized patients, increasing the number of treatment options for COVID-19 patients at different stages of the disease. This is an important milestone for hospitalized patients on oxygen, as baricitinib may help speed their recovery."Patients treated with the drug in combination with remdesivir had a "significant reduction in median time to recovery," according to the press release.Baricitinib has not been approved by the FDA to treat COVID-19 and studies are still underway in clinical trials, according to the press release.Eli Lilly and Company is working with healthcare systems and governments to facilitate patient access to the drug."With respect to supply, Lilly remains confident in being able to meet the needs of patients under the EUA in the U.S., as well as for existing approved indications around the world," the press release read. To learn more about the drug, click here.Earlier this month, Eli Lilly and Company received an emergency use authorization for its experimental COVID-19 antibody treatment.This article was written by Andrew Smith for WRTV. 1984

Its 5:30 p.m. and most of the 20 and 30-year-old students in this class have just come here from a day at work. But now, they’re here to learn the basics of buying auto insurance.It’s part of a unique initiative called the 236

来源：资阳报